Evidence map›Paper›PMID 30970430›Full record

ArticleGut and liver2019

Novel Prognostic Nomograms for Hepatocellular Carcinoma Patients with Microvascular Invasion: Experience from a Single Center.

Liangliang Xu, Lian Li, Peng Wang, Ming Zhang, Yanfang Zhang, Xiangyong Hao, Lvnan Yan, Bo Li, Tianfu Wen, Mingqing Xu

Abstract read
In one paragraph

Article in Gut and liver, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Advances in post-operative prognostic models for hepatocellular carcinoma.Journal of Zhejiang University. Science. B · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Liangliang XuDepartment of Liver Surgery, Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0002-3900-9972
Lian LiDepartment of Liver Surgery, Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0002-8517-4661
Peng WangDepartment of Liver Surgery, Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0001-5889-1115
Ming ZhangDepartment of Liver Surgery, Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0002-8276-691X
Yanfang ZhangCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0001-7614-0067
Xiangyong HaoDepartment of General Surgery, Gansu Provincial Hospital, Lanzhou, China.ORCID 0000-0003-4419-7047
Lvnan YanDepartment of Liver Surgery, Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0003-1371-8903
Bo LiDepartment of Liver Surgery, Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0001-6572-5633
Tianfu WenDepartment of Liver Surgery, Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0002-8260-7601
Mingqing XuDepartment of Liver Surgery, Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0002-8556-0802

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/Aims: Microvascular invasion (MVI) is an established risk factor for hepatocellular carcinoma (HCC). However, prediction models that specifically focus on the individual prognoses of HCC patients with MVI is lacking. Methods: A total of 385 HCC patients with MVI were randomly assigned to training and validation cohorts in a 2:1 ratio. The outcomes were disease-free survival (DFS) and overall survival (OS). Prognostic nomograms were established based on the results of multivariate analyses. The concordance index (C-index), calibration plots and Kaplan-Meier curves were employed to evaluate the accuracy, calibration and discriminatory ability of the models. Results: The independent risk factors for both DFS and OS included age, tumor size, tumor number, the presence of gross vascular invasion, and the presence of Glisson's capsule invasion. The platelet-to-lymphocyte ratio was another risk factor for OS. On the basis of these predictors, two nomograms for DFS and OS were constructed. The C-index values of the nomograms for DFS and OS were 0.712 (95% confidence interval [CI], 0.679 to 0.745; p<0.001) and 0.698 (95% CI, 0.657 to 0.739; p<0.001), respectively, in the training cohort and 0.704 (95% CI, 0.650 to 0.708; p<0.001) and 0.673 (95% CI, 0.607 to 0.739; p<0.001), respectively, in the validation cohort. The calibration curves showed optimal agreement between the predicted and observed survival rates. The Kaplan-Meier curves suggested that these two nomograms had satisfactory discriminatory abilities. Conclusions: These novel predictive models have satisfactory accuracy and discriminatory abilities in predicting the prognosis of HCC patients with MVI after hepatectomy.

Indexed as

NomogramsAdultCarcinoma, HepatocellularCohort StudiesDisease-Free SurvivalFemaleHepatectomyHepatic VeinsHumansLiver NeoplasmsMaleMiddle AgedNeoplasm InvasivenessNeoplastic Cells, CirculatingPortal SystemPredictive Value of TestsCarcinoma, hepatocellularHepatectomyMicrovascular invasionNomogramPrognosis

Identifiers

PMID30970430
PMCPMC6860039

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.